Latest Articles
ATM IHC Identifies POLE-Mutant Endometrial Cancer - Conexiant
ATM IHC Identifies POLE-Mutant Endometrial Cancer Conexiant
Published: April 2, 2026, 9:11 p.m.
Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival? - The ASCO Post
Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival? The ASCO Post
Published: April 2, 2026, 4:19 p.m.
Endometrial Cancer Treatment Options: What are the Experts Using? - CancerNetwork
Endometrial Cancer Treatment Options: What are the Experts Using? CancerNetwork
Published: March 31, 2026, 7:43 p.m.
Endometrial Cancer Treatment Options: What are the Experts Using? - cancernetwork.com
Endometrial Cancer Treatment Options: What are the Experts Using? cancernetwork.com
Published: March 31, 2026, 7:43 p.m.
Frontline IO-Combos, Next-Generation ADCs: Evolutions in Endometrial Cancer - CancerNetwork
Frontline IO-Combos, Next-Generation ADCs: Evolutions in Endometrial Cancer CancerNetwork
Published: March 30, 2026, 8:07 p.m.
SGO 2026 Preview: Endometrial and Ovarian Cancer - Medscape
SGO 2026 Preview: Endometrial and Ovarian Cancer Medscape
Published: March 30, 2026, 5:59 p.m.
Without Pain and Biopsy: A New Test System for Diagnosing Endometrial Cancer Invented in Russia - www1.ru
Without Pain and Biopsy: A New Test System for Diagnosing Endometrial Cancer Invented in Russia www1.ru
Published: March 30, 2026, 8:45 a.m.
Histopathological Evaluation of Endometrial Patterns in Women With Postmenopausal Bleeding and Their Correlation With Clinical and Radiological Features - Cureus
Histopathological Evaluation of Endometrial Patterns in Women With Postmenopausal Bleeding and Their Correlation With Clinical and Radiological Features Cureus
Published: March 28, 2026, 4:48 p.m.
Expanding the Standard of Care: Dostarlimab for Advanced Endometrial Cancer - Pharmacy Times
Expanding the Standard of Care: Dostarlimab for Advanced Endometrial Cancer Pharmacy Times
Published: March 28, 2026, 2:58 a.m.
Projecting the Global Endometrial Ablation Devices Market Size to Expand at a 5.21% CAGR Through 2032, DelveInsight Analysis - Barchart
Projecting the Global Endometrial Ablation Devices Market Size to Expand at a 5.21% CAGR Through 2032, DelveInsight Analysis Barchart
Published: March 27, 2026, 1:44 p.m.
Link copied to clipboard!